Cavusoglu, Y. Et Al. 2013. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study. Congress of the European-Society-of-Cardiology (ESC) , (Amsterdam, Netherlands), 1064-1065.

Cavusoglu, Y., Korkmaz, S., Demirtas, S., Gencer, E., Sasmaz, H., Mutlu, F., ... YILMAZ, M. B.(2013). Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study . Congress of the European-Society-of-Cardiology (ESC) (pp.1064-1065). Amsterdam, Netherlands

Cavusoglu, Y. Et Al. "Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study," Congress of the European-Society-of-Cardiology (ESC), Amsterdam, Netherlands, 2013

Cavusoglu, Y. Et Al. "Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study." Congress of the European-Society-of-Cardiology (ESC) , Amsterdam, Netherlands, pp.1064-1065, 2013

Cavusoglu, Y. Et Al. (2013) . "Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study." Congress of the European-Society-of-Cardiology (ESC) , Amsterdam, Netherlands, pp.1064-1065.

@conferencepaper{conferencepaper, author={Y. Cavusoglu Et Al. }, title={Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study}, congress name={Congress of the European-Society-of-Cardiology (ESC)}, city={Amsterdam}, country={Netherlands}, year={2013}, pages={1064-1065} }